実はガチ痩せした患者さんの9割がやってる...！　GLP-1とメトホルミンの飲み合わせで確実に結果が出ます。

👉️ Manjaro's online consultations are available via [Official LINE] https://lstep.app/zXFPzsp ◆━━━━━━━━━━━━━━━━━━◆ \ Achieve your last diet ever! 🔥 / ✅ Say goodbye to strict exercise and diet restrictions! ✅ Over 10,000 successful cases! Knowledge and clinical experience based on medical evidence ✅ Thorough follow-up after prescription \ For consultations and online consultations, please use our official LINE 💁‍♂️ / Dr. Kenshin will respond directly! https://lstep.app/zXFPzsp ▼Video Table of Contents▼ 00:00 About this video 00:34 Mechanism of action of metformin and GLP-1 01:54 How much weight can you lose with these two drugs? 04:44 Who is metformin suitable for? 06:52 Is it okay to use metformin and GLP-1 together? 10:03 What are the prices of metformin and GLP-1? ●Official LINE https://lstep.app/zXFPzsp ●Instagram   / tsukuba_ken_clinic   ●TikTok   / diet_dr.kenshin   ●Homepage https://tsukuken.clinic 🔹We are recruiting colleagues to work with us | About physician and staff recruitment Tsukuba Ken Clinic is working on new forms of medical care, including online private medical care, online insurance-covered medical care, general outpatient care, and preventive medicine. We value flexible responses and teamwork to deliver the medical care each patient needs, rather than a uniform approach. We are looking for colleagues who will grow together and create better medical care. 📍【Recruitment Information & Entry Here】 ▶︎ https://tsukuken.clinic/recruit/ *Please check the link above for details on specific job titles, duties, and working styles. ────────────────── [About Treatment Details] (Disclosure of Important Information) 1. About Medical Treatment and Prescriptions at Our Clinic At our clinic, we may prescribe type 2 diabetes medications (GLP-1 receptor agonists, SGLT2 inhibitors, metformin, etc.) as private medical treatment (for the purpose of obesity treatment) at the discretion of the physician. Since the use of these medications for the purpose of obesity treatment is not approved in Japan, this constitutes off-label use. We will make a comprehensive judgment based on the examination, test results, and medical history, and we cannot prescribe them to all patients. 2. Main Purpose and Indications of Treatment All of these medications are approved for the purpose of blood glucose control in type 2 diabetes. Use for obesity treatment will be carried out with sufficient explanation and consent, taking into account the approval status in Japan and overseas, and academic society guidelines. 3. Individual Differences in Efficacy, Side Effects, and Risks Taking these medications or injecting them does not necessarily guarantee a certain level of weight loss. There are significant individual differences in effectiveness, and it is essential to use them in combination with lifestyle changes, dietary therapy, and exercise therapy. Side effects such as hypoglycemia and gastrointestinal symptoms may occur. If you experience any discomfort, please consult a doctor immediately. 4. Possibility of Tests and Additional Treatment Regular tests (blood, urine, etc.) may be necessary to continue treatment. Consultation fees, test fees, and additional medication costs may be incurred separately. 5. Precautions Regarding Private Medical Treatment Prescriptions for obesity treatment are not covered by health insurance (full self-payment). Because it is off-label use, it may not be covered by the national drug side effect relief system. 6. Comparison with Other Treatment Methods and Guarantees This treatment is merely one option and does not guarantee superiority over other medical institutions or other treatment methods. Treatment effectiveness and the risk of side effects vary from person to person, and the expected results are not always guaranteed. ────────────────── ●GLP-1 Receptor Agonist (Oral Medication: Rybelsus) 【Treatment Details】 Rybelsus is an oral GLP-1 receptor agonist, used for blood glucose control in type 2 diabetes. At our clinic, it may be prescribed for obesity treatment at the doctor's discretion (off-label use). Weight loss is expected due to its appetite-suppressing effect and sustained feeling of fullness. [Dosage and Administration] Take once daily before breakfast with 120 mL or less of water. Avoid eating or drinking for 30 minutes after taking the medication (to maximize its effect). The initial dose is 3 mg, increasing to 7 mg after one month, and can be increased up to 14 mg as needed. [Standard Cost] Rybelsus 3 mg 30-day supply: ¥8,480 7 mg 30-day supply: ¥18,480 14 mg 30-day supply: ¥26,980 [Main Risks and Side Effects] Gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), loss of appetite, acute pancreatitis (extremely rare) [Regarding the Use of Unapproved Drugs] Rybelsus is approved by the Ministry of Health, Labour and Welfare as a treatment for type 2 diabetes, but its prescription for the treatment of obesity is...